Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Taiwan Bio Therapeutics Co., Ltd (6892) operate in?
Taiwan Bio Therapeutics Co., Ltd belongs to the Other sector and operates in the Biotechnology industry.
What is Taiwan Bio Therapeutics Co., Ltd (6892) current stock price?
As of the latest data, Taiwan Bio Therapeutics Co., Ltd stock price is NT$24.35, with a previous close of NT$24.35.
What is Taiwan Bio Therapeutics Co., Ltd (6892) current market capitalization?
Taiwan Bio Therapeutics Co., Ltd market cap is approximately 2.29 billion.
What is Taiwan Bio Therapeutics Co., Ltd (6892) Earnings Per Share (EPS)?
The trailing EPS is -NT$4.51.
Does Taiwan Bio Therapeutics Co., Ltd (6892) pay dividends?
No. Taiwan Bio Therapeutics Co., Ltd does not pay a dividend.
What is Taiwan Bio Therapeutics Co., Ltd (6892) beta (volatility) score?
Taiwan Bio Therapeutics Co., Ltd has a beta of 0.018, indicating lower volatility than the overall market.